Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

被引：0
|
作者：
Demosthenes Makris
Arnaud Scherpereel
Marie Christine Copin
Guillaume Colin
Luc Brun
Jean Jacques Lafitte
Charles Hugo Marquette
机构：
[1] CHRU of Lille,Pulmonary and Thoracic Oncology Department
[2] INSERM Unit 774,Pathology Department
[3] Institut Pasteur of Lille,Clinique des Maladies Respiratoires
[4] CHRU of Lille,undefined
[5] Hôpital Albert Calmette,undefined
[6] CHRU de Lille,undefined
来源：
BMC Cancer | / 7卷
关键词：
Docetaxel; Gemcitabine; Human Epidermal Growth Factor Receptor; Erlotinib; Interstitial Lung Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinically amyotrophic dermatornyositis with fatal interstitial lung disease
    Bernez, A
    Machet, L
    Diot, P
    Legras, A
    Vaillant, L
    Lorette, G
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2005, 132 (01): : 52 - 53
  • [42] FATAL INTERSTITIAL PNEUMONITIS ASSOCIATED WITH DOCETAXEL THERAPY IN AN ADVANCED NON-SMALL-CELL LUNG CANCER PATIENT
    Yang, L.
    Wang, C-H
    RESPIROLOGY, 2011, 16 : 176 - 176
  • [43] Successful Erlotinib Rechallenge After Erlotinib-Induced Interstitial Lung Disease (ild)
    Wang, X.
    Zhao, H. Q.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease
    Hagiwara, Yasuhito
    Nakayama, Yuko
    Kudo, Shigehiro
    Hayakawa, Toyokazu
    Nakamura, Naoki
    Kitamoto, Yoshizumi
    Takahashi, Shigeo
    Tsujino, Kayoko
    Kubo, Nobuteru
    Tamaki, Yukihisa
    Nagata, Yasushi
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (04) : 563 - 574
  • [45] Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease
    Heluain, Valentin
    Prevot, Gregoire
    Cabarrou, Bastien
    Calvayrac, Olivier
    Clermont, Estelle
    Didier, Alain
    Milia, Julie
    Mazieres, Julien
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [46] Interstitial lung disease associated with amrubicin in the treatment of patients with small cell lung cancer
    Yoh, K.
    Nishiwaki, Y.
    Kemmotsu, H.
    Yamaguchi, Y.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Management of lung cancer in patients with interstitial lung disease
    Verghese, P.
    Jayaprakash, K. Thippu
    Yip, K.
    Screaton, N.
    Parfrey, H.
    Simler, N.
    Gilligan, D.
    Thillai, M.
    LUNG CANCER, 2020, 139 : S87 - S88
  • [48] Does interstitial lung disease predispose to lung cancer?
    Daniels, CE
    Jett, JR
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 431 - 437
  • [49] Management of Lung Cancer in the Patient with Interstitial Lung Disease
    Frank, Angela J.
    Dagogo-Jack, Ibiayi
    Dobre, Ioana A.
    Tait, Sarah
    Schumacher, Lana
    Fintelmann, Florian J.
    Fingerman, Leah M.
    Keane, Florence K.
    Montesi, Sydney B.
    ONCOLOGIST, 2023, 28 (01): : 12 - 22
  • [50] Lung cancer and interstitial lung disease: a literature review
    Naccache, Jean-Marc
    Gibiot, Quentin
    Monnet, Isabelle
    Antoine, Martine
    Wislez, Marie
    Chouaid, Christos
    Cadranel, Jacques
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3829 - +
12345